XML 47 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment and Related Information (Tables)
3 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Schedule of Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense

Segment revenue and operating income (loss) were as follows during the periods presented:

 

 

 

Diagnostics

 

 

Other

 

 

Total

 

Three months ended September 30, 2017

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

178.8

 

 

$

11.4

 

 

$

190.2

 

Depreciation and amortization

 

 

11.8

 

 

 

1.4

 

 

 

13.2

 

Segment operating income (loss)

 

 

34.0

 

 

 

53.4

 

 

 

87.4

 

Three months ended September 30, 2016

 

 

 

 

 

 

 

 

 

 

 

 

Revenues

 

$

165.1

 

 

$

12.4

 

 

$

177.5

 

Depreciation and amortization

 

 

7.8

 

 

 

1.4

 

 

 

9.2

 

Segment operating income (loss)

 

 

30.1

 

 

 

(24.4

)

 

 

5.7

 

 

 

 

Three months ended

 

 

 

September 30,

 

 

 

2017

 

 

2016

 

Total operating income for reportable segments

 

$

87.4

 

 

$

5.7

 

Unallocated amounts:

 

 

 

 

 

 

 

 

Interest income

 

 

0.4

 

 

 

0.3

 

Interest expense

 

 

(0.9

)

 

 

(0.7

)

Other

 

 

(0.3

)

 

 

(1.3

)

Income from operations before income taxes

 

 

86.6

 

 

 

4.0

 

Income tax provision

 

 

5.6

 

 

 

5.2

 

Net income

 

 

81.0

 

 

 

(1.2

)

Net loss attributable to non-controlling interest

 

 

(0.1

)

 

 

 

Net income attributable to Myriad Genetics, Inc.

   stockholders

 

$

81.1

 

 

$

(1.2

)